BOP1 is widely recognized as an oncogene in hepatocellular carcinoma and several other cancers, where it promotes epithelial-to-mesenchymal transition (EMT) and correlates with poor prognosis across pan-cancer cohorts (51–53). This evidence concerns the gene BOP1 and hepatocellular carcinoma.